A pathophysiological paradigm for the therapy of psychiatric disease
- PMID: 15931256
- DOI: 10.1038/nrd1753
A pathophysiological paradigm for the therapy of psychiatric disease
Abstract
Despite enormous progress in fundamental knowledge in neuroscience, no revolutionary therapies in psychiatry (and neurology) have emerged in the past ten years. Most drugs alleviate symptoms, rather than restoring the 'set point' of brain function from a pathological position to a more normal one. We propose a hypothesis-driven, systems-level approach to drug discovery and development that is based on pathophysiology and which uses new animal models.
Similar articles
-
Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy.Eur J Pharmacol. 2008 Apr 7;583(2-3):372-8. doi: 10.1016/j.ejphar.2007.07.072. Epub 2008 Jan 19. Eur J Pharmacol. 2008. PMID: 18272147 Review.
-
[The importance of circadian periodicity factors for the action of psychotropic substances].Farmakol Toksikol. 1984 May-Jun;47(3):13-25. Farmakol Toksikol. 1984. PMID: 6145620 Review. Russian. No abstract available.
-
[Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry].Bibl Psychiatr. 1976;(155):1-245. Bibl Psychiatr. 1976. PMID: 802167 Review. German. No abstract available.
-
Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.J Psychopharmacol. 2006 Jul;20(4 Suppl):85-94. doi: 10.1177/1359786806066070. J Psychopharmacol. 2006. PMID: 16785276 Review.
-
Discontinued psychiatric drugs in 2008.Expert Opin Investig Drugs. 2009 Oct;18(10):1431-43. doi: 10.1517/13543780903184591. Expert Opin Investig Drugs. 2009. PMID: 19715445
Cited by
-
A case series evaluating the accuracy of manual muscle testing for predicting fetal sex.J Chiropr Med. 2012 Mar;11(1):1-6. doi: 10.1016/j.jcm.2011.06.010. J Chiropr Med. 2012. PMID: 22942835 Free PMC article.
-
Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.Br J Pharmacol. 2009 Nov;158(6):1565-78. doi: 10.1111/j.1476-5381.2009.00432.x. Br J Pharmacol. 2009. PMID: 19906119 Free PMC article.
-
Neurobiological and clinical effects of the antidepressant tianeptine.CNS Drugs. 2008;22(1):15-26. doi: 10.2165/00023210-200822010-00002. CNS Drugs. 2008. PMID: 18072812 Review.
-
Boosting serotonin in the brain: is it time to revamp the treatment of depression?J Psychopharmacol. 2012 May;26(5):629-35. doi: 10.1177/0269881111430744. Epub 2011 Dec 8. J Psychopharmacol. 2012. PMID: 22158544 Free PMC article.
-
Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule.Mol Psychiatry. 2013 Apr;18(4):471-84. doi: 10.1038/mp.2012.80. Epub 2012 Jun 26. Mol Psychiatry. 2013. PMID: 22733125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous